Cite
CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
MLA
Neault, Mathieu, et al. “CBFA2T3-GLIS2-Dependent Pediatric Acute Megakaryoblastic Leukemia Is Driven by GLIS2 and Sensitive to Navitoclax.” Cell Reports, vol. 42, no. 9, Sept. 2023, p. 113084. EBSCOhost, https://doi.org/10.1016/j.celrep.2023.113084.
APA
Neault, M., Lebert-Ghali, C.-É., Fournier, M., Capdevielle, C., Garfinkle, E. A. R., Obermayer, A., Cotton, A., Boulay, K., Sawchyn, C., St-Amand, S., Nguyen, K. H., Assaf, B., Mercier, F. E., Delisle, J.-S., Drobetsky, E. A., Hulea, L., Shaw, T. I., Zuber, J., Gruber, T. A., … Mallette, F. A. (2023). CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax. Cell Reports, 42(9), 113084. https://doi.org/10.1016/j.celrep.2023.113084
Chicago
Neault, Mathieu, Charles-Étienne Lebert-Ghali, Marilaine Fournier, Caroline Capdevielle, Elizabeth A R Garfinkle, Alyssa Obermayer, Anitria Cotton, et al. 2023. “CBFA2T3-GLIS2-Dependent Pediatric Acute Megakaryoblastic Leukemia Is Driven by GLIS2 and Sensitive to Navitoclax.” Cell Reports 42 (9): 113084. doi:10.1016/j.celrep.2023.113084.